agritech
Commented by Nico Popp on August 25th, 2026 | 07:00 CEST
Goodbye to Chemical Pesticides: Bayer Partner MustGrow Biologics Makes Progress – Has Bioceres Overreached?
Created and Published on Behalf of MustGrow Biologics Corp.
Agriculture is at a turning point. Strict environmental regulations are increasingly pushing chemical crop-protection products off the fields. At the same time, the effects of climate change are creating additional challenges. This puts farmers in a difficult position: on the one hand, they need to secure yields, while on the other, they must comply with increasingly stringent regulations. The solution could lie in biological alternatives to conventional chemical pesticides. This market is growing rapidly and opening up opportunities for innovative companies. We take a look at the latest trends and highlight some exciting companies.
Read
Commented by Matthias Schomber on August 24th, 2026 | 07:30 CEST
Return Opportunities in Defence, Hydrogen and GreenTech: How Deutz, Nel ASA and MustGrow Biologics Are Gearing Up for a Breakout!
Created and Published on Behalf of MustGrow Biologics Corp.
Trump's hard-line stance in the Iran conflict and the blockade of the Strait of Hormuz have been keeping the financial markets on edge for weeks and months. This issue will likely remain with us for quite some time. However, these geopolitical crises are currently causing massive shifts in market weightings, with defence-related stocks gaining renewed momentum while many former "hydrogen hype" stocks continue to lose ground. Deutz AG, for example, is pivoting toward the defence technology sector with billion-euro acquisitions, thereby striking exactly the right chord with current market sentiment. Nel ASA, by contrast, is experiencing the opposite: despite a strong order book, weak margins continue to weigh on the stock. Away from these two companies, MustGrow Biologics, a smaller company operating in a niche market, is making headway. The Canadian agri-biotech specialist is making strides in sustainable crop protection and may be on the verge of a technical breakout.
Read
Commented by Stefan Bode on August 20th, 2026 | 07:30 CEST
Stock Market Reality Check: When the Numbers Alone Are No Longer Enough – Infineon, Klarna and MustGrow Biologics
Created and Published on Behalf of MustGrow Biologics Corp.
Between sharp sell-offs and opportunities to scale, it becomes clear just how quickly the stock market reassesses expectations. One company suddenly delivers profits—and is still punished because its outlook turns lower. A growth stock must raise fresh capital to meet strong demand. And in the cyclical semiconductor industry, solid quarterly results are often not enough when bond yields rise and risk appetite shifts. For investors looking to understand what is really driving these market moves, the underlying pattern becomes clear.
Read
Commented by André Will-Laudien on August 12th, 2026 | 08:05 CEST
Heat, Drought, and Water Shortages: A Sector-Wide Buy Signal for Environmental Specialists Bayer, MustGrow, Kraft Heinz and Unilever
Created and Published on Behalf of MustGrow Biologics Corp.
The devastating combination of persistent drought, acute water shortages, and extreme heat is creating unprecedented challenges for the global economy and food supply. As climate-related risks intensify, ESG considerations are moving into sharper focus than ever before. Amid this crisis, a potential technical and fundamental buy signal is emerging across sectors for companies capable of delivering innovative environmental solutions. Agricultural and chemical companies such as Bayer are developing advanced seed technologies designed to make crops more resilient during periods of extreme drought. At the same time, the AgriTech company MustGrow is gaining importance as its biological fertilizer and crop protection solutions are designed to protect soil health and improve water efficiency in agriculture, among other things. Food giants such as Unilever and Kraft Heinz are also responding proactively by strictly optimizing their entire supply chains to minimize water consumption and resource intensity. Investors are increasingly recognizing that sustainable business practices in modern times are no longer merely an image factor, but rather a catalyst for future returns.
Read
Commented by Fabian Lorenz on August 11th, 2026 | 07:15 CEST
Sell Rheinmetall Shares? Over 20% Gains in One Week! Buy Rating for OHB! Bayer Partner MustGrow Begins Re-Rating
Created and Published on Behalf of MustGrow Biologics Corp.
MustGrow Biologics shares climbed more than 20% last week, potentially marking the beginning of a long-awaited re-rating. Analysts believe significantly higher prices are achievable. Revenue is expected to multiply over the coming years, with the company also targeting substantial profitability. MustGrow could also benefit from milestone payments from its partner, Bayer. These potential payments are not included in current analyst estimates, potentially providing additional upside. At Rheinmetall, analysts are lowering their 2028 revenue estimates. Experts also see risks regarding cash flow and margins. As a result, they have downgraded the shares of Germany's largest defence contractor from "Hold" to "Sell." Analysts are considerably more optimistic about OHB. A key element of the investment case is the expectation that the German space-industry hopeful will secure major contracts over the coming months.
Read
Commented by Armin Schulz on August 7th, 2026 | 07:25 CEST
Bayer, MustGrow Biologics, and Nutrien: Feeding the World Means Leading the Future of Agriculture
Created and Published on Behalf of MustGrow Biologics Corp.
Global food security remains under pressure from geopolitical conflicts, extreme weather events, and resource scarcity. These challenges are placing agricultural production under growing strain. With the world's population continuing to expand, transforming agriculture has become a critical priority. As a result, the agricultural technology sector is emerging as a key driver of innovation. Established industry leaders are adapting their product portfolios to meet the demands of a changing climate, while agile biotech companies are accelerating the development of sustainable alternatives to conventional chemical crop protection products. Today, we take a closer look at Bayer, MustGrow Biologics, and Nutrien—three companies that are well positioned to shape the future agricultural value chain.
Read
Commented by Stefan Bode on August 7th, 2026 | 07:00 CEST
AI Scaling and Agricultural Strength Meet an E-Commerce Correction: Bayer, Miivo, and Zalando
Created and Published on Behalf of Miivo AI Inc.
The current earnings season vividly illustrates how differently market participants react to companies' fundamental developments. In this report, we examine three highly compelling players from the e-commerce, AI software, and agri-pharma sectors. While a well-known European online retailer is losing massive market value following its earnings guidance revision, a Canadian software provider is successfully scaling its AI solutions for small and medium-sized businesses. At the same time, a well-established global industrial and life sciences company is generating bullish technical signals, supported by strong margins in its agricultural business. Find out all the details here!
Read
Commented by Nico Popp on August 4th, 2026 | 11:00 CEST
Agribusiness Sector Heats Up: BASF, MustGrow Biologics, and Corteva—Where Growth Is Scaling and What Analysts Recommend
Created and Published on Behalf of MustGrow Biologics Corp.
Investments in the agribusiness sector are often viewed as resilient long-term opportunities, driven by steadily growing global food demand. However, the industry's outlook is becoming increasingly complex. Climate change and tightening regulations are forcing agricultural companies to adapt continuously. To feed an estimated 9.7 billion people by 2050, experts believe global food production must increase significantly despite a shrinking amount of arable land. At the same time, regulators around the world are moving to phase out conventional crop protection products. The EU aims to have 25% of agricultural land under organic farming by 2030 and has already banned many conventional crop protection products. These developments are creating significant opportunities for biological alternatives. We take a closer look at the market and the companies best positioned to benefit from these long-term trends.
Read
Commented by André Will-Laudien on August 1st, 2026 | 07:05 CEST
AI and Smart Farming: Growth Opportunities with BASF, MustGrow, SAP, and Nestlé
Created and Published on Behalf of MustGrow Biologics Corp.
Devastating wildfires in Spain and southern France are no longer a rare occurrence. Climate change is taking an increasing toll. Alongside technological progress, we must ensure that the natural resources we depend on—clean water, clean air, and healthy ecosystems—are preserved for future generations. The smart farming approach is transforming agriculture through the targeted use of digital technologies such as drones, artificial intelligence (AI), and IoT sensors. These innovations enable farms to precisely manage resources like water and energy while improving yield forecasting and operational efficiency. A key pillar of this transformation is a stronger focus on sustainability and the protection of natural ecosystems. From this perspective, biological fertilizers are becoming increasingly important, as they help maintain long-term soil health, unlike many synthetic alternatives. Investors stand to benefit in more ways than one. Companies that combine sustainability with technological innovation are well positioned to capitalize on powerful long-term trends. In this report, we take a closer look at the opportunities.
Read
Commented by Fabian Lorenz on July 30th, 2026 | 10:00 CEST
Analysts Turn Bullish: Multi-Bagger Potential? TeamViewer, Atoss Software and MustGrow Biologics
Created and Published on Behalf of MustGrow Biologics Corp.
GBC Research sees significant re-rating potential for MustGrow and its mustard-based biologicals platform. The analysts have set a price target of EUR 1.66, while the shares are currently trading at approximately EUR 0.19. By 2028, GBC forecasts earnings per share of CAD 0.11, excluding any potential profits from the company's collaboration with Bayer. For TeamViewer, analysts expect the second quarter of 2026 to mark the beginning of operational improvements, particularly in the enterprise customer segment, which they believe offers substantial growth potential. However, not all analysts share this optimistic view, with some remaining cautious on the German software company. Analysts are also bullish on Atoss Software. The key question now is whether the shares can climb to EUR 135.
Read